Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Galbusera

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 11, 2011
Membranous nephropathy associated with IgG4-related diseasePaolo Cravedi, Mauro Abbate, Elena Gagliardini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 7, 2011
Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosisMarina Morigi, Miriam Galbusera, Sara Gastoldi, et al.
Kidney International Reports|November 13, 2024
Exuberant Endothelial C5b-9 Formation in Recurrent and <i>De Novo</i> Posttransplant Thrombotic MicroangiopathySistiana Aiello, Sara Gastoldi, Elena Bresin, et al.
Blood|April 14, 2005
Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case reportMiriam Galbusera, Elena Bresin, Marina Noris, et al.
Blood Advances|December 1, 2021
C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19Sistiana Aiello, Sara Gastoldi, Miriam Galbusera, et al.
Diabetes|June 5, 2013
ADAMTS13 predicts renal and cardiovascular events in type 2 diabetic patients and response to therapyErica Rurali, Marina Noris, Antonietta Chianca, et al.
Frontiers in Immunology|March 30, 2026
Molecular determinants of STEC-HUS: from complement activation to microvascular thrombosisDonata Santarsiero, Miriam Galbusera, Sara Gastoldi, et al.
Blood|July 20, 2014
Dynamics of complement activation in aHUS and how to monitor eculizumab therapyMarina Noris, Miriam Galbusera, Sara Gastoldi, et al.
Blood|May 14, 2005
ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseasesManfred Rieger, Pier Mannuccio Mannucci, Johanna A Kremer Hovinga, et al.
Ebiomedicine|July 3, 2015
Mitochondrial-dependent Autoimmunity in Membranous Nephropathy of IgG4-related DiseaseSimona Buelli, Luca Perico, Miriam Galbusera, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 11, 2011
Membranous nephropathy associated with IgG4-related diseasePaolo Cravedi, Mauro Abbate, Elena Gagliardini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 7, 2011
Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosisMarina Morigi, Miriam Galbusera, Sara Gastoldi, et al.
Kidney International Reports|November 13, 2024
Exuberant Endothelial C5b-9 Formation in Recurrent and <i>De Novo</i> Posttransplant Thrombotic MicroangiopathySistiana Aiello, Sara Gastoldi, Elena Bresin, et al.
Blood|April 14, 2005
Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case reportMiriam Galbusera, Elena Bresin, Marina Noris, et al.
Blood Advances|December 1, 2021
C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19Sistiana Aiello, Sara Gastoldi, Miriam Galbusera, et al.
Diabetes|June 5, 2013
ADAMTS13 predicts renal and cardiovascular events in type 2 diabetic patients and response to therapyErica Rurali, Marina Noris, Antonietta Chianca, et al.
Frontiers in Immunology|March 30, 2026
Molecular determinants of STEC-HUS: from complement activation to microvascular thrombosisDonata Santarsiero, Miriam Galbusera, Sara Gastoldi, et al.
Blood|July 20, 2014
Dynamics of complement activation in aHUS and how to monitor eculizumab therapyMarina Noris, Miriam Galbusera, Sara Gastoldi, et al.
Blood|May 14, 2005
ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseasesManfred Rieger, Pier Mannuccio Mannucci, Johanna A Kremer Hovinga, et al.
Ebiomedicine|July 3, 2015
Mitochondrial-dependent Autoimmunity in Membranous Nephropathy of IgG4-related DiseaseSimona Buelli, Luca Perico, Miriam Galbusera, et al.
Pageof 4